p53 Mutants Have Selective Dominant-Negative Effects on Apoptosis but Not Growth Arrest in Human Cancer Cell Lines
AUTOR(ES)
Aurelio, Oscar N.
FONTE
American Society for Microbiology
RESUMO
A bidirectional expression vector that allowed equal transcription of cloned wild-type and mutant p53 cDNAs from the same vector was developed. The vector was transfected into CaLu 6 lung carcinoma cells or Saos-2 osteosarcoma cells. All p53 mutants examined were recessive to wild-type p53 transactivation of p21WAF1/CIP1 but dominant-negative for transactivation of Bax. An examination of effects on growth arrest and apoptotic pathways indicated that all mutants were recessive to wild type for growth arrest but only three of seven mutants were dominant negative for induction of apoptosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=85193Documentos Relacionados
- Dominant-negative p53 mutations selected in yeast hit cancer hot spots.
- Characterization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle Arrest
- Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
- Fragments of ATM which have dominant-negative or complementing activity.
- Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.
